Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to describe the long-term safety of a fixed combination product
containing an alternative preservative, dosed once daily for 12 months, in patients with
open-angle glaucoma or ocular hypertension.